一个非糖尿病女性的复发性低血糖症:Doege-Potter综合征的案例研究
Saeed R Mohammed1, Narine Mack2, Valmikie Ramoutar2
1Department of Clinical Medical Sciences, The University of the West Indies, St. Augustine Campus, Champs Fleurs, TTO.
Cureus
|July 30, 2024
概括
孤独纤维性瘤 (SFT) 可能导致杜格-波特综合征 (DPS),导致严重的低血糖症. 这一案例突出了这种罕见疾病患者的息护理管理.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 病理学 病理学 病理学
背景情况:
- 孤独性纤维性瘤 (SFT) 是一种罕见的间瘤,具有多种来源.
- 一部分SFT患者患有非岛屿细胞瘤诱导低血糖症 (NICTH),称为Doege-Potter综合征 (DPS).
- DPS呈现为严重的,耐火性低胰岛素性低血糖症.
研究的目的:
- 报告一个73岁女性Doege-Potter综合征 (DPS) 的病例.
- 讨论SFT相关低血糖的诊断和管理策略.
- 强调息治疗在处理复杂病例中的作用.
主要方法:
- 组织学检查和免疫组织化学 (IHC) 用于SFT诊断.
- 评估STAT6 IHC作为NAB2-STAT6基因融合的替代品.
- 临床评估和低血糖的管理.
- 瘤管理的息护理方法.
主要成果:
- 患者呈现出与Doege-Potter综合征 (DPS) 相一致的症状.
- 通过组织学和IHC证实了SFT的诊断.
- STAT6 IHC被用作一个诊断标记.
- 息护理作为管理策略被实施.
结论:
- 孤独纤维性瘤 (SFT) 是非岛屿细胞瘤诱导的低血糖症 (NICTH/DPS) 的重要原因.
- STAT6 IHC是诊断SFT的一个有价值的工具.
- 当完全切除不可能时,息性瘤解和护理至关重要.
- 这个案例强调了在临床实践中识别和管理DPS的重要性.
相关概念视频
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229
Pathophysiology of Diabetes
913
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
913
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K


